Exicure, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XCUR research report →
Companywww.exicuretx.com
Exicure, Inc. , a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain.
- CEO
- Jungsoo Kim
- IPO
- 2018
- Employees
- 7
- HQ
- Chicago, IL, US
Price Chart
Valuation
- Market Cap
- $18.04M
- P/E
- -3.60
- P/S
- 0.00
- P/B
- 4.54
- EV/EBITDA
- -1.50
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -63.62%
- ROIC
- -36.10%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-4,946,000 · 49.02%
- EPS
- $-0.79 · 50.31%
- Op Income
- $-10,117,000
- FCF YoY
- -194.02%
Performance & Tape
- 52W High
- $10.80
- 52W Low
- $2.68
- 50D MA
- $3.81
- 200D MA
- $4.64
- Beta
- 3.62
- Avg Volume
- 18.12K
Get TickerSpark's AI analysis on XCUR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 16, 26 | Miller Josh | other | 8 |
| Jan 21, 26 | Exicure HiTron Inc. | sell | 258,367 |
| Jan 16, 26 | Exicure HiTron Inc. | sell | 734,747 |
| Jan 7, 26 | Exicure HiTron Inc. | sell | 741,272 |
| Dec 8, 25 | SANGSANGIN INVESTMENT & SECURITIES CO., LTD. | sell | 433,332 |
| Nov 16, 25 | Miller Josh | other | 7 |
| Sep 8, 25 | Hwang Aejin | other | 0 |
| Sep 8, 25 | Yeo Sangjin | other | 0 |
| Aug 16, 25 | Miller Josh | other | 9 |
| May 16, 25 | Miller Josh | other | 8 |
Our XCUR Coverage
We haven't published any research on XCUR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate XCUR Report →